PROGRAMME
WEDNESDAY 5 NOVEMBER 2008
Room Prince Pierre  
18.00-19.00 Congress opening
19.00-20.00 Welcome Cocktail
 
THURSDAY 6 NOVEMBER 2008
 
Session 1
Room Camille Blanc
 
08.30-10.00 BASIC MECHANISMS - Adult track
• Innate immunity
• Neurogenic pathways
• Th-17 cell interaction with tissue cells
• IgE and inflammation: implications in asthma and rhinitis
Session 2
Room Auric
 
08.30-10.00 DIAGNOSIS OF ASTHMA IN CHILDREN - Pediatric track
• Allergic diagnosis in asthma - PRACTALL
• Pulmonary lung function from infancy to adulthood
• Monitoring airway inflammation
• Moulds and asthma

Session 3
Room Van Dongen

 
08.30-10.00 DIAGNOSIS OF ALLERGY AND ASTHMA
In vitro allergy diagnosis
• Inflammatory parameters in respiratory allergy
• Flow cytometry in airway inflammation
• Exhaled breath temperature measurement
10.00-10.15 Coffee break
Plenary session 1
Room Camille Blanc
 
10.15-11.45 FROM GENES TO THE ALLERGIC MARCH
• Environment-gene interaction in the airways
• Does remodeling exist in children?
• B2-adrenoceptor polimorphysm
• The allergic march: is time to reappraise it?
Plenary session 2
Room Prince Pierre
 
11.45-13.15 EAACI SYMPOSIUM: Asthma exacerbations
• Exacerbation vs. loss of asthma control
• New viruses as cause of exacerbation
• Innate immunity in the pathogenesis of virus-induced asthma exacerbation
• Virus infection and reversal of tolerance to allergens in asthma exacerbations
Room Van Dongen  
13.15-14.30 Lunch and Lunchtime lecture
Osteoporosis and bone fractures in the pneumological clinical
practice: how to assess the risk and how to manage it ?
Symposium 1
Room Prince Pierre
 
14.30-16.00

ASTHMA AND ALLERGY: Why are we still discussing them?
• Achievements in progress: the tribute to success in management of allergies
• Published progress and harsh reality in today’s allergies: have they gone different ways?
• Compliance to data or compliance to perceptions: what is best for our patients?
• Seeing should be believing: making the right choices for our allergic patients

Sponsored by an unrestricted educational grant of UCB

16.00-16.15 Tea break
Plenary session 3
Room Camille Blanc
 
16.15-17.45 EPIDEMIOLOGY OF ASTHMA
• Occupational aspects of respiratory diseases
• Update on epidemiology of asthma
• What have we learnt from ISAAC phase 3
• Socio-economic aspect in Europe and rest of the world
Session 4
Room Camille Blanc
 
17.45-19.15 FACTORS ASSOCIATED WITH ASTHMA - Adult track
• Smooth muscle, asthma and obesity
• Global warming and climatic changes and its impact on allergy and respiratory
• Role of tobacco smoking in chronic respiratory diseases
• Asthma in immigrants
Session 5
Room Auric
 
17.45-19.15 RISK FACTORS AND CO-MORBIDITIES - Pediatric track
• Hygiene hypothesis and airway inflammation
• The role of indoor allergens
• Food allergy and asthma
• Rhinosinusitis in children
   
FRIDAY 7 NOVEMBER 2008
 
Session 6
Room Camille Blanc
 
08.30-10.00 IS IT ASTHMA OR COPD? - Adult track
• Controversies in the pathogenesis of COPD
• Immunology of asthma and COPD
• Asthma and COPD: similarities and differences
• What is new in the treatment of COPD
Session 7
Room Auric
 
08.30-10.00 PARTICULAR ASPECTS OF ASTHMA IN CHILDREN - Pediatric track
• Recurrent cough and pertussis
• Asthma severity and atopic eczema
• Natural history of asthma from childhood to adulthood
• Virus-induced asthma in children: what is new?
Session 8
Room Van Dongen
 
08.30-10.00 SEVERE ASTHMA AND RISK FACTORS - Adult track
• Asthma heterogeneity: different phenotypes
• Sinusitis and asthma
• NSAID and asthma: beyond sinus and polyps
• Severe asthma: a different disease?
10.00-10.15 Coffee break
Plenary session 4
Room Prince Pierre
 
10.15-11.45 INTERASMA-WAO SYMPOSIUM: Allergy and Asthma
• Epithelial disfunction
• Role of regulatory T cells in atopic and non atopic subjects
• RSV and airway inflammation: implications for asthma
• Immunological aspects of airways remodeling and possible
modulation
Plenary session 5
Room Camille Blanc
 
11.45-13.15 GARD: Global Alliance against chronic Respiratory Diseases
• Global burden of chronic respiratory disease
• Asthma in children: from epidemiology to action plan
• COPD: present and future in the world
• Public health interventions
13.15-14.30 Lunch and Lunchtime lecture
Symposium 2
Room Prince Pierre
 
14.30-16.00

NEW PERSPECTIVES IN ASTHMA MANAGEMENT: A chance beyond the central airways
• GINA 2006: A clearer guideline to asthma control
• Therapeutic approaches to Asthma control: step up or Step down?
• Small Airways: The burning Point of inflammation in Asthma
• Cellular and molecular interactions between ICS and LABA
• The ultimate synergy in asthma control

Sponsored by an unrestricted educational grant of UCB

16.00-16.15 Tea break
Plenary session 6
Room Prince Pierre
 
16.15-17.45 GUIDELINES IN ASTHMA AND OTHER CRD 2008
• ARIA (Allergic Rhinitis and its Impact on asthma). An EBM approach 2008
• British guidelines for cough in children
• GINA
• ATS / ERS Guidelines on COPD
Session 9
Room Camille Blanc
 
17.45-19.15 INHALED CORTICOSTEROIDS - Adult track
• ICS in asthma and COPD: friends and foes
• ICS as rescue medication in acute asthma
• ICS in different guidelines
• Choosing the right inhaler for patients with asthma
Session 10
Room Auric
 
17.45-19.15 TREATMENT OF ASTHMA IN CHILDREN - Pediatric track
• Is anti-microbial therapy an option to treat asthma/allergy?
• Allergen avoidance: does it work in asthma?
• Immunotherapy in rhinitis and asthma
• Management of rhinitis in children with asthma

Session 11
Room Van Dongen
 
17.45-19.15 EAACI SESSION
• The pathogenesis of exercise-induced asthma in sport medicine
• Diagnosis of asthma in sport and exercise medicine: lessons from the Olimpic games
• The epidemiology and treatment of asthma in sport and exercise medicine
• Rhinitis and asthma-like conditions in athletes
   
SATURDAY 8 NOVEMBER 2008
   
Session 12
Room Camille Blanc
 
08.30-10.00 TREATMENT OF ASTHMA 2 - Adult track
• The LABA controversy: revising the evidence
• New drugs for asthma treatment
• Severe refractory asthma: what do we need?
• Ultra long-acting beta agonists
Session 13
Room Auric
 
08.30-10.30 PHARMOCOLOGIC AND NON PHARMACOLOGIC MANAGEMENT - Pediatric track
• Leucotrienes receptor antagonist: alone or add-on
• Barriers to adherence with pharmacotherapy
• Management of acute asthma attack
• QoL in childhood asthma: is the same than asthma control?
Session 14
Room Van Dongen
 
08.30-10.30 MEDITERRANEAN THORACIC SOCIETY - INTERASMA SYMPOSIUM
• Genetics in severe asthma
• Asthma and air pollution
10.30-10.45 Coffee break
Semi Plenary session 1
Room Camille Blanc
 
10.45-12.45 IMMUNOTHERAPY: present and future
• EBM and immunotherapy: from study design to meta-analysis
• Lessons from big SLIT trials
• Immunological mechanisms of specific immunotherapy
• Specific immunotherapy in childhood
Semi Plenary session 2
Room Van Dongen
 
10.45-12.45 ASTHMA AROUND THE WORLD
• Asthma in children in the Middle East
• Mites, parasites and asthma in Latin America
• Asthma in the developing world of Eastern Europe
• Treating asthma in low-income groups in South Africa
• Korea: Computer assisted easy asthma management
12.45-13.00 CLOSING OF THE MEETING